| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Behavior | 70 | 2021 | 839 | 12.290 |
Why?
|
| Netherlands | 245 | 2022 | 2170 | 11.970 |
Why?
|
| Child Behavior Disorders | 47 | 2023 | 807 | 10.980 |
Why?
|
| Prenatal Exposure Delayed Effects | 91 | 2024 | 2408 | 10.420 |
Why?
|
| Child Development | 69 | 2023 | 2223 | 7.500 |
Why?
|
| Parenting | 28 | 2024 | 679 | 6.450 |
Why?
|
| Hydrocortisone | 37 | 2023 | 1826 | 6.200 |
Why?
|
| Mother-Child Relations | 26 | 2020 | 481 | 6.100 |
Why?
|
| Mothers | 70 | 2024 | 2165 | 5.570 |
Why?
|
| Depression | 96 | 2023 | 7766 | 5.300 |
Why?
|
| Intelligence | 33 | 2024 | 920 | 5.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 45 | 2024 | 3658 | 4.740 |
Why?
|
| Pregnancy Complications | 53 | 2024 | 2861 | 4.300 |
Why?
|
| Object Attachment | 16 | 2019 | 313 | 4.290 |
Why?
|
| Bullying | 12 | 2024 | 210 | 4.200 |
Why?
|
| Depressive Disorder | 43 | 2023 | 3748 | 4.170 |
Why?
|
| Pregnancy | 244 | 2024 | 29144 | 4.150 |
Why?
|
| Child | 347 | 2024 | 77709 | 3.820 |
Why?
|
| Thyroxine | 24 | 2023 | 667 | 3.790 |
Why?
|
| Maternal Behavior | 16 | 2019 | 311 | 3.580 |
Why?
|
| Sleep | 38 | 2023 | 4623 | 3.550 |
Why?
|
| Fetal Development | 32 | 2021 | 767 | 3.520 |
Why?
|
| Anxiety Disorders | 33 | 2021 | 2690 | 3.440 |
Why?
|
| Brain | 101 | 2024 | 26385 | 3.340 |
Why?
|
| Fathers | 17 | 2022 | 358 | 3.220 |
Why?
|
| Female | 680 | 2024 | 380194 | 3.200 |
Why?
|
| Mental Disorders | 44 | 2023 | 6600 | 3.190 |
Why?
|
| Autistic Disorder | 20 | 2023 | 1185 | 3.190 |
Why?
|
| Circadian Rhythm | 22 | 2020 | 2624 | 3.070 |
Why?
|
| Child, Preschool | 197 | 2023 | 41006 | 2.930 |
Why?
|
| Prospective Studies | 214 | 2023 | 53288 | 2.910 |
Why?
|
| Grief | 7 | 2017 | 247 | 2.870 |
Why?
|
| Cohort Studies | 216 | 2023 | 40561 | 2.830 |
Why?
|
| Male | 547 | 2024 | 350118 | 2.700 |
Why?
|
| Aggression | 20 | 2022 | 753 | 2.690 |
Why?
|
| Stress, Psychological | 32 | 2021 | 4245 | 2.640 |
Why?
|
| Genome-Wide Association Study | 99 | 2023 | 12261 | 2.610 |
Why?
|
| Cognition | 51 | 2024 | 6770 | 2.590 |
Why?
|
| Humans | 810 | 2024 | 744343 | 2.580 |
Why?
|
| Actigraphy | 15 | 2020 | 488 | 2.570 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 10 | 2020 | 304 | 2.500 |
Why?
|
| Polymorphism, Single Nucleotide | 88 | 2022 | 15519 | 2.490 |
Why?
|
| Longitudinal Studies | 99 | 2023 | 13989 | 2.450 |
Why?
|
| Executive Function | 20 | 2022 | 1364 | 2.440 |
Why?
|
| Iodine | 11 | 2021 | 286 | 2.420 |
Why?
|
| Infant Behavior | 10 | 2019 | 156 | 2.370 |
Why?
|
| Infant | 143 | 2023 | 35136 | 2.370 |
Why?
|
| Pesticides | 9 | 2020 | 287 | 2.330 |
Why?
|
| Maternal Exposure | 22 | 2024 | 961 | 2.300 |
Why?
|
| DNA Methylation | 28 | 2023 | 4286 | 2.280 |
Why?
|
| Thyrotropin | 22 | 2023 | 849 | 2.250 |
Why?
|
| Feeding Behavior | 23 | 2019 | 3188 | 2.240 |
Why?
|
| Breast Feeding | 13 | 2022 | 1338 | 2.150 |
Why?
|
| Birth Weight | 27 | 2023 | 2069 | 2.140 |
Why?
|
| Temperament | 11 | 2015 | 283 | 2.100 |
Why?
|
| Crime Victims | 6 | 2024 | 322 | 2.080 |
Why?
|
| Parent-Child Relations | 12 | 2020 | 747 | 2.010 |
Why?
|
| Fetal Blood | 26 | 2023 | 1318 | 1.930 |
Why?
|
| Mortality | 16 | 2019 | 2864 | 1.930 |
Why?
|
| Gestational Age | 39 | 2022 | 3493 | 1.920 |
Why?
|
| Saliva | 18 | 2017 | 809 | 1.920 |
Why?
|
| Infant, Newborn | 102 | 2024 | 25625 | 1.830 |
Why?
|
| Emotions | 19 | 2023 | 2661 | 1.800 |
Why?
|
| Child Abuse | 11 | 2021 | 1030 | 1.780 |
Why?
|
| Child of Impaired Parents | 7 | 2022 | 455 | 1.710 |
Why?
|
| Father-Child Relations | 4 | 2020 | 48 | 1.680 |
Why?
|
| Depressive Disorder, Major | 23 | 2021 | 4644 | 1.650 |
Why?
|
| Psychopathology | 11 | 2023 | 409 | 1.610 |
Why?
|
| Body Mass Index | 47 | 2023 | 12720 | 1.600 |
Why?
|
| Affective Symptoms | 10 | 2019 | 407 | 1.570 |
Why?
|
| Psychiatric Status Rating Scales | 39 | 2022 | 6038 | 1.570 |
Why?
|
| Peer Group | 8 | 2021 | 635 | 1.560 |
Why?
|
| Pituitary-Adrenal System | 13 | 2018 | 553 | 1.550 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 10 | 2020 | 322 | 1.540 |
Why?
|
| Longevity | 15 | 2021 | 1070 | 1.530 |
Why?
|
| Behavioral Symptoms | 6 | 2020 | 175 | 1.530 |
Why?
|
| Aging | 25 | 2022 | 8664 | 1.500 |
Why?
|
| Anxiety | 27 | 2023 | 4297 | 1.470 |
Why?
|
| Hair | 9 | 2023 | 483 | 1.440 |
Why?
|
| Educational Status | 23 | 2024 | 2540 | 1.430 |
Why?
|
| Adoption | 5 | 2010 | 97 | 1.420 |
Why?
|
| Adult | 247 | 2024 | 214055 | 1.410 |
Why?
|
| Multifactorial Inheritance | 21 | 2024 | 1194 | 1.410 |
Why?
|
| Language Development | 8 | 2015 | 187 | 1.390 |
Why?
|
| Thyroid Gland | 13 | 2023 | 1173 | 1.380 |
Why?
|
| Parents | 27 | 2022 | 3407 | 1.380 |
Why?
|
| Folic Acid | 16 | 2020 | 1300 | 1.350 |
Why?
|
| Epigenesis, Genetic | 28 | 2023 | 3647 | 1.350 |
Why?
|
| Mental Health | 19 | 2023 | 3019 | 1.330 |
Why?
|
| Crying | 4 | 2023 | 36 | 1.330 |
Why?
|
| Schools | 12 | 2024 | 1433 | 1.330 |
Why?
|
| Population Surveillance | 23 | 2018 | 2616 | 1.320 |
Why?
|
| Internal-External Control | 7 | 2017 | 363 | 1.300 |
Why?
|
| Genetic Predisposition to Disease | 56 | 2022 | 17446 | 1.300 |
Why?
|
| Magnetic Resonance Imaging | 62 | 2023 | 35421 | 1.290 |
Why?
|
| Vitamin D Deficiency | 11 | 2021 | 1343 | 1.290 |
Why?
|
| Motor Skills Disorders | 3 | 2018 | 90 | 1.260 |
Why?
|
| Risk Factors | 133 | 2023 | 72290 | 1.250 |
Why?
|
| Language Development Disorders | 5 | 2016 | 196 | 1.230 |
Why?
|
| Diffusion Tensor Imaging | 22 | 2024 | 2305 | 1.230 |
Why?
|
| Autonomic Nervous System | 4 | 2016 | 671 | 1.220 |
Why?
|
| Dementia | 17 | 2022 | 2518 | 1.220 |
Why?
|
| Paternal Behavior | 3 | 2018 | 32 | 1.220 |
Why?
|
| Aged | 174 | 2023 | 163280 | 1.210 |
Why?
|
| Developmental Disabilities | 9 | 2018 | 1456 | 1.200 |
Why?
|
| Cross-Sectional Studies | 65 | 2023 | 25043 | 1.200 |
Why?
|
| Adolescent | 110 | 2024 | 85781 | 1.190 |
Why?
|
| Thyroid Hormones | 7 | 2019 | 390 | 1.180 |
Why?
|
| Dyssomnias | 2 | 2018 | 29 | 1.180 |
Why?
|
| Health Status | 15 | 2019 | 4034 | 1.180 |
Why?
|
| Ultrasonography, Prenatal | 17 | 2021 | 1695 | 1.150 |
Why?
|
| Hypothyroidism | 8 | 2016 | 658 | 1.140 |
Why?
|
| Self Report | 26 | 2022 | 3558 | 1.120 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2017 | 1953 | 1.110 |
Why?
|
| Body Weight | 12 | 2019 | 4669 | 1.110 |
Why?
|
| Air Pollution | 14 | 2024 | 2286 | 1.100 |
Why?
|
| Juvenile Delinquency | 4 | 2021 | 125 | 1.100 |
Why?
|
| Happiness | 4 | 2017 | 170 | 1.100 |
Why?
|
| Child Rearing | 3 | 2019 | 74 | 1.100 |
Why?
|
| Linear Models | 33 | 2023 | 5952 | 1.100 |
Why?
|
| Vitamin D | 15 | 2021 | 3223 | 1.090 |
Why?
|
| Parturition | 5 | 2019 | 441 | 1.090 |
Why?
|
| Pregnancy Trimester, First | 14 | 2019 | 853 | 1.090 |
Why?
|
| Organophosphorus Compounds | 5 | 2021 | 215 | 1.070 |
Why?
|
| Age Factors | 48 | 2021 | 18370 | 1.060 |
Why?
|
| Smoking | 29 | 2022 | 8987 | 1.060 |
Why?
|
| Antidepressive Agents | 14 | 2023 | 2838 | 1.060 |
Why?
|
| Head | 9 | 2018 | 880 | 1.060 |
Why?
|
| Geriatric Assessment | 10 | 2018 | 1372 | 1.060 |
Why?
|
| Hostility | 3 | 2018 | 189 | 1.050 |
Why?
|
| Middle Aged | 173 | 2023 | 213383 | 1.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 12 | 2018 | 703 | 1.030 |
Why?
|
| Personal Satisfaction | 7 | 2020 | 643 | 1.020 |
Why?
|
| Self Disclosure | 4 | 2016 | 251 | 1.000 |
Why?
|
| Beds | 2 | 2015 | 48 | 0.990 |
Why?
|
| Pregnancy Trimester, Second | 11 | 2021 | 732 | 0.980 |
Why?
|
| Life Style | 10 | 2023 | 3835 | 0.980 |
Why?
|
| Environment | 10 | 2021 | 1124 | 0.970 |
Why?
|
| Psychotic Disorders | 10 | 2023 | 3046 | 0.950 |
Why?
|
| Anti-Anxiety Agents | 3 | 2017 | 390 | 0.950 |
Why?
|
| Family | 14 | 2021 | 3147 | 0.950 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 12 | 2021 | 378 | 0.950 |
Why?
|
| Aged, 80 and over | 86 | 2022 | 57776 | 0.940 |
Why?
|
| Loneliness | 4 | 2022 | 185 | 0.940 |
Why?
|
| Sexual Behavior | 3 | 2018 | 2057 | 0.920 |
Why?
|
| Folic Acid Deficiency | 4 | 2020 | 115 | 0.910 |
Why?
|
| Bulimia Nervosa | 3 | 2014 | 177 | 0.900 |
Why?
|
| Intelligence Tests | 17 | 2020 | 505 | 0.880 |
Why?
|
| Vocabulary | 5 | 2023 | 169 | 0.880 |
Why?
|
| Neuropsychological Tests | 26 | 2021 | 6993 | 0.870 |
Why?
|
| Cerebellum | 6 | 2023 | 1488 | 0.870 |
Why?
|
| Cognition Disorders | 12 | 2017 | 4043 | 0.860 |
Why?
|
| Air Pollutants | 9 | 2022 | 2817 | 0.860 |
Why?
|
| Social Behavior | 10 | 2021 | 1127 | 0.850 |
Why?
|
| Schizophrenia | 16 | 2022 | 6882 | 0.840 |
Why?
|
| Cerebral Cortex | 10 | 2020 | 5708 | 0.840 |
Why?
|
| Bipolar Disorder | 11 | 2022 | 5027 | 0.840 |
Why?
|
| Hallucinations | 5 | 2022 | 360 | 0.830 |
Why?
|
| Iodide Peroxidase | 10 | 2019 | 293 | 0.820 |
Why?
|
| Creatinine | 5 | 2021 | 1919 | 0.820 |
Why?
|
| Genotype | 38 | 2020 | 12951 | 0.820 |
Why?
|
| Thalamus | 4 | 2021 | 1023 | 0.810 |
Why?
|
| Deficiency Diseases | 2 | 2021 | 72 | 0.800 |
Why?
|
| Adiposity | 7 | 2023 | 1807 | 0.790 |
Why?
|
| Receptors, Dopamine D4 | 7 | 2018 | 171 | 0.790 |
Why?
|
| Fatty Acids, Omega-6 | 7 | 2017 | 227 | 0.780 |
Why?
|
| Social Class | 8 | 2019 | 1999 | 0.770 |
Why?
|
| Psychometrics | 13 | 2022 | 3002 | 0.770 |
Why?
|
| Obesity | 22 | 2023 | 12745 | 0.770 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2021 | 544 | 0.770 |
Why?
|
| Socioeconomic Factors | 34 | 2018 | 7785 | 0.760 |
Why?
|
| Thyroid Diseases | 6 | 2019 | 379 | 0.760 |
Why?
|
| Receptors, Glucocorticoid | 6 | 2020 | 302 | 0.760 |
Why?
|
| Depression, Postpartum | 8 | 2022 | 340 | 0.750 |
Why?
|
| Interpersonal Relations | 6 | 2015 | 1425 | 0.740 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2012 | 245 | 0.740 |
Why?
|
| Body Composition | 9 | 2021 | 2401 | 0.740 |
Why?
|
| Family Conflict | 2 | 2019 | 95 | 0.740 |
Why?
|
| Phthalic Acids | 6 | 2024 | 436 | 0.730 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2022 | 1004 | 0.730 |
Why?
|
| Sleep Deprivation | 5 | 2016 | 832 | 0.730 |
Why?
|
| Cortisone | 3 | 2018 | 89 | 0.730 |
Why?
|
| Adolescent Development | 1 | 2023 | 278 | 0.730 |
Why?
|
| Emotional Intelligence | 4 | 2015 | 136 | 0.720 |
Why?
|
| Life Expectancy | 8 | 2017 | 1184 | 0.720 |
Why?
|
| Premature Birth | 13 | 2022 | 1721 | 0.720 |
Why?
|
| Affect | 5 | 2017 | 1476 | 0.720 |
Why?
|
| Follow-Up Studies | 49 | 2022 | 39050 | 0.710 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2020 | 89 | 0.710 |
Why?
|
| Hair Color | 2 | 2017 | 136 | 0.710 |
Why?
|
| Pregnancy Outcome | 11 | 2021 | 2795 | 0.710 |
Why?
|
| Social Isolation | 2 | 2023 | 365 | 0.710 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2021 | 546 | 0.700 |
Why?
|
| Tacrolimus Binding Proteins | 4 | 2017 | 195 | 0.700 |
Why?
|
| Acculturation | 2 | 2018 | 182 | 0.690 |
Why?
|
| Phlebotomy | 2 | 2011 | 141 | 0.690 |
Why?
|
| Divorce | 2 | 2019 | 79 | 0.680 |
Why?
|
| Attention | 11 | 2021 | 2400 | 0.680 |
Why?
|
| Cerebrovascular Disorders | 5 | 2022 | 1504 | 0.680 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 151 | 0.670 |
Why?
|
| Overweight | 9 | 2021 | 2371 | 0.670 |
Why?
|
| Environmental Pollutants | 5 | 2024 | 1179 | 0.660 |
Why?
|
| Family Characteristics | 10 | 2022 | 1000 | 0.660 |
Why?
|
| Parasomnias | 1 | 2018 | 26 | 0.660 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2017 | 615 | 0.660 |
Why?
|
| Heart Rate | 7 | 2017 | 4091 | 0.650 |
Why?
|
| Amygdala | 7 | 2023 | 1315 | 0.650 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 159 | 0.640 |
Why?
|
| Noise, Transportation | 3 | 2023 | 50 | 0.640 |
Why?
|
| Dexamethasone | 2 | 2016 | 1951 | 0.640 |
Why?
|
| Comorbidity | 24 | 2023 | 10388 | 0.640 |
Why?
|
| Pregnancy Trimester, Third | 7 | 2018 | 571 | 0.640 |
Why?
|
| Cholesterol | 7 | 2023 | 2917 | 0.640 |
Why?
|
| Interview, Psychological | 4 | 2020 | 812 | 0.640 |
Why?
|
| Psychiatry | 3 | 2023 | 1695 | 0.630 |
Why?
|
| Facial Expression | 4 | 2023 | 508 | 0.630 |
Why?
|
| Hippocampus | 6 | 2021 | 3675 | 0.630 |
Why?
|
| Young Adult | 68 | 2023 | 56430 | 0.630 |
Why?
|
| Asphyxia Neonatorum | 1 | 2019 | 107 | 0.630 |
Why?
|
| Epidemiologic Research Design | 8 | 2017 | 367 | 0.630 |
Why?
|
| Fetus | 11 | 2021 | 1880 | 0.620 |
Why?
|
| Pigments, Biological | 1 | 2017 | 53 | 0.620 |
Why?
|
| Prevalence | 29 | 2022 | 15226 | 0.610 |
Why?
|
| Infant, Premature | 6 | 2022 | 2044 | 0.610 |
Why?
|
| Cerebral Ventricles | 3 | 2012 | 544 | 0.610 |
Why?
|
| Independent Living | 3 | 2018 | 568 | 0.610 |
Why?
|
| Community Health Planning | 10 | 2018 | 165 | 0.600 |
Why?
|
| Poverty | 5 | 2023 | 2660 | 0.600 |
Why?
|
| Memory, Short-Term | 6 | 2023 | 975 | 0.600 |
Why?
|
| Motor Skills | 3 | 2020 | 522 | 0.600 |
Why?
|
| Personality Assessment | 5 | 2015 | 647 | 0.600 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2017 | 230 | 0.600 |
Why?
|
| Pyramidal Tracts | 1 | 2019 | 256 | 0.590 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.590 |
Why?
|
| Cardiovascular Diseases | 22 | 2021 | 15165 | 0.590 |
Why?
|
| Life Change Events | 5 | 2023 | 938 | 0.590 |
Why?
|
| Muscle Tonus | 1 | 2017 | 81 | 0.590 |
Why?
|
| Logistic Models | 22 | 2019 | 13408 | 0.590 |
Why?
|
| Genetic Loci | 12 | 2022 | 2575 | 0.590 |
Why?
|
| Risk | 22 | 2017 | 9687 | 0.580 |
Why?
|
| Sex Characteristics | 13 | 2023 | 2585 | 0.580 |
Why?
|
| Pigmentation | 1 | 2017 | 148 | 0.580 |
Why?
|
| Psychomotor Performance | 7 | 2017 | 1901 | 0.580 |
Why?
|
| Motor Activity | 4 | 2021 | 2714 | 0.570 |
Why?
|
| Brain Mapping | 8 | 2022 | 6669 | 0.570 |
Why?
|
| Crowding | 2 | 2014 | 145 | 0.560 |
Why?
|
| Antisocial Personality Disorder | 5 | 2021 | 228 | 0.560 |
Why?
|
| Rest | 3 | 2020 | 901 | 0.560 |
Why?
|
| Infant, Small for Gestational Age | 7 | 2021 | 440 | 0.560 |
Why?
|
| Residence Characteristics | 7 | 2015 | 2050 | 0.560 |
Why?
|
| Brain Waves | 1 | 2020 | 401 | 0.550 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2010 | 260 | 0.550 |
Why?
|
| Maternal Health Services | 3 | 2021 | 455 | 0.550 |
Why?
|
| Genetic Pleiotropy | 2 | 2018 | 182 | 0.550 |
Why?
|
| Maternal Age | 8 | 2023 | 802 | 0.550 |
Why?
|
| Middle Cerebral Artery | 2 | 2021 | 264 | 0.550 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2019 | 1344 | 0.550 |
Why?
|
| Anorexia Nervosa | 3 | 2014 | 1286 | 0.540 |
Why?
|
| Corpus Callosum | 4 | 2019 | 737 | 0.540 |
Why?
|
| Adolescent Behavior | 3 | 2021 | 1151 | 0.540 |
Why?
|
| Emigration and Immigration | 2 | 2009 | 404 | 0.530 |
Why?
|
| Infant Food | 2 | 2017 | 141 | 0.530 |
Why?
|
| Marital Status | 2 | 2017 | 437 | 0.530 |
Why?
|
| Iron-Binding Proteins | 5 | 2019 | 79 | 0.530 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 253 | 0.530 |
Why?
|
| Particulate Matter | 13 | 2022 | 2530 | 0.530 |
Why?
|
| Muscle Hypotonia | 1 | 2017 | 165 | 0.530 |
Why?
|
| Temporal Lobe | 4 | 2024 | 1670 | 0.520 |
Why?
|
| Seasons | 4 | 2018 | 1493 | 0.520 |
Why?
|
| Cephalometry | 6 | 2018 | 382 | 0.520 |
Why?
|
| Neurobiology | 2 | 2020 | 121 | 0.520 |
Why?
|
| Placental Insufficiency | 2 | 2021 | 51 | 0.520 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2023 | 967 | 0.520 |
Why?
|
| Exercise | 8 | 2023 | 5615 | 0.520 |
Why?
|
| Activity Cycles | 1 | 2015 | 51 | 0.520 |
Why?
|
| Adjustment Disorders | 2 | 2015 | 70 | 0.520 |
Why?
|
| Sex Factors | 24 | 2020 | 10397 | 0.510 |
Why?
|
| Food Preferences | 5 | 2017 | 399 | 0.510 |
Why?
|
| Asthma | 7 | 2020 | 6011 | 0.500 |
Why?
|
| Bedding and Linens | 1 | 2014 | 41 | 0.500 |
Why?
|
| Health Surveys | 9 | 2020 | 4037 | 0.500 |
Why?
|
| Sex Offenses | 1 | 2019 | 354 | 0.500 |
Why?
|
| Achievement | 1 | 2016 | 291 | 0.500 |
Why?
|
| Research Design | 14 | 2023 | 5987 | 0.500 |
Why?
|
| Frontal Lobe | 3 | 2018 | 1406 | 0.490 |
Why?
|
| Phenotype | 29 | 2023 | 16365 | 0.490 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2015 | 582 | 0.490 |
Why?
|
| Environmental Exposure | 18 | 2023 | 4234 | 0.490 |
Why?
|
| Reactive Attachment Disorder | 2 | 2011 | 38 | 0.480 |
Why?
|
| Infant Care | 1 | 2015 | 183 | 0.480 |
Why?
|
| Fear | 6 | 2017 | 1440 | 0.480 |
Why?
|
| Dietary Supplements | 8 | 2020 | 3297 | 0.480 |
Why?
|
| Echoencephalography | 3 | 2012 | 135 | 0.470 |
Why?
|
| Child Language | 2 | 2012 | 64 | 0.470 |
Why?
|
| Waist Circumference | 5 | 2019 | 917 | 0.470 |
Why?
|
| Caregivers | 3 | 2016 | 2094 | 0.470 |
Why?
|
| Checklist | 7 | 2017 | 833 | 0.470 |
Why?
|
| Faculty | 2 | 2014 | 386 | 0.460 |
Why?
|
| Family Relations | 2 | 2013 | 321 | 0.460 |
Why?
|
| Fetal Weight | 5 | 2016 | 80 | 0.460 |
Why?
|
| Punishment | 1 | 2014 | 98 | 0.460 |
Why?
|
| Nerve Net | 4 | 2023 | 2174 | 0.450 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2703 | 0.450 |
Why?
|
| Sweden | 6 | 2022 | 1345 | 0.450 |
Why?
|
| C-Reactive Protein | 5 | 2017 | 3778 | 0.450 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 347 | 0.450 |
Why?
|
| CpG Islands | 9 | 2023 | 1172 | 0.440 |
Why?
|
| Eating | 4 | 2017 | 1536 | 0.440 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 5 | 2014 | 284 | 0.440 |
Why?
|
| Infant Welfare | 2 | 2012 | 81 | 0.440 |
Why?
|
| Sleep, REM | 2 | 2015 | 595 | 0.430 |
Why?
|
| Quantitative Trait Loci | 7 | 2021 | 2019 | 0.430 |
Why?
|
| Pregnancy, Unplanned | 1 | 2013 | 95 | 0.430 |
Why?
|
| Benzodiazepines | 2 | 2017 | 1101 | 0.430 |
Why?
|
| Diet | 9 | 2021 | 7939 | 0.430 |
Why?
|
| Infant, Postmature | 1 | 2012 | 11 | 0.430 |
Why?
|
| Culture | 3 | 2017 | 633 | 0.430 |
Why?
|
| Wakefulness | 4 | 2020 | 1245 | 0.420 |
Why?
|
| Nutritional Status | 6 | 2017 | 1609 | 0.420 |
Why?
|
| Anthropometry | 7 | 2018 | 1350 | 0.420 |
Why?
|
| Thyroid Function Tests | 9 | 2023 | 286 | 0.420 |
Why?
|
| Basal Ganglia | 3 | 2018 | 546 | 0.420 |
Why?
|
| Homozygote | 4 | 2016 | 1785 | 0.420 |
Why?
|
| Gene Frequency | 12 | 2018 | 3588 | 0.420 |
Why?
|
| Expressed Emotion | 1 | 2012 | 92 | 0.420 |
Why?
|
| Cholesterol, HDL | 7 | 2023 | 1814 | 0.420 |
Why?
|
| Polymorphism, Genetic | 12 | 2019 | 4328 | 0.410 |
Why?
|
| Pregnancy Trimesters | 3 | 2019 | 192 | 0.410 |
Why?
|
| Carotid Artery Diseases | 3 | 2010 | 882 | 0.410 |
Why?
|
| Time Factors | 27 | 2020 | 40075 | 0.400 |
Why?
|
| Hypnotics and Sedatives | 2 | 2017 | 1162 | 0.400 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2022 | 1444 | 0.400 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 2418 | 0.390 |
Why?
|
| Monoamine Oxidase | 2 | 2009 | 178 | 0.390 |
Why?
|
| Autoantigens | 5 | 2019 | 892 | 0.390 |
Why?
|
| Blood Flow Velocity | 3 | 2021 | 1423 | 0.390 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1941 | 0.390 |
Why?
|
| Epidemiologic Methods | 4 | 2010 | 1364 | 0.390 |
Why?
|
| Secretory Pathway | 1 | 2011 | 51 | 0.390 |
Why?
|
| Polysomnography | 4 | 2019 | 1776 | 0.390 |
Why?
|
| Glucocorticoids | 2 | 2023 | 2107 | 0.380 |
Why?
|
| Models, Statistical | 4 | 2022 | 5102 | 0.380 |
Why?
|
| Survival | 1 | 2011 | 163 | 0.380 |
Why?
|
| Fruit | 2 | 2018 | 1142 | 0.370 |
Why?
|
| Individuality | 2 | 2022 | 307 | 0.370 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2011 | 164 | 0.360 |
Why?
|
| Regression Analysis | 9 | 2018 | 6459 | 0.360 |
Why?
|
| Postpartum Period | 4 | 2019 | 1086 | 0.360 |
Why?
|
| Phenols | 4 | 2020 | 497 | 0.360 |
Why?
|
| Coffee | 4 | 2016 | 578 | 0.350 |
Why?
|
| Receptors, Oxytocin | 3 | 2016 | 66 | 0.350 |
Why?
|
| Homocysteine | 5 | 2016 | 647 | 0.350 |
Why?
|
| Odds Ratio | 13 | 2022 | 9849 | 0.350 |
Why?
|
| Atherosclerosis | 5 | 2023 | 3445 | 0.350 |
Why?
|
| Statistics as Topic | 6 | 2017 | 2373 | 0.350 |
Why?
|
| Functional Laterality | 6 | 2021 | 2290 | 0.350 |
Why?
|
| Ischemic Attack, Transient | 2 | 2016 | 935 | 0.350 |
Why?
|
| Area Under Curve | 7 | 2017 | 1654 | 0.350 |
Why?
|
| Retinal Vessels | 2 | 2017 | 772 | 0.350 |
Why?
|
| Photoperiod | 1 | 2009 | 136 | 0.340 |
Why?
|
| Proportional Hazards Models | 15 | 2022 | 12354 | 0.340 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2013 | 482 | 0.340 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1092 | 0.340 |
Why?
|
| Electromagnetic Fields | 2 | 2021 | 298 | 0.340 |
Why?
|
| Registries | 6 | 2017 | 8089 | 0.340 |
Why?
|
| Stroke | 12 | 2022 | 9981 | 0.340 |
Why?
|
| Human Development | 3 | 2019 | 124 | 0.340 |
Why?
|
| Child Psychiatry | 1 | 2011 | 220 | 0.330 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2016 | 116 | 0.330 |
Why?
|
| Behavior | 3 | 2019 | 561 | 0.330 |
Why?
|
| Quality of Life | 11 | 2018 | 12804 | 0.330 |
Why?
|
| Mood Disorders | 3 | 2013 | 1106 | 0.330 |
Why?
|
| Transcortin | 2 | 2021 | 13 | 0.320 |
Why?
|
| Nitrogen Dioxide | 5 | 2022 | 490 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2015 | 456 | 0.320 |
Why?
|
| Periodicity | 1 | 2009 | 363 | 0.320 |
Why?
|
| Adult Children | 1 | 2009 | 100 | 0.320 |
Why?
|
| Case-Control Studies | 25 | 2021 | 21746 | 0.320 |
Why?
|
| Autoimmunity | 2 | 2017 | 1349 | 0.320 |
Why?
|
| Fatty Acids | 4 | 2019 | 1809 | 0.310 |
Why?
|
| Psychomotor Disorders | 1 | 2009 | 152 | 0.310 |
Why?
|
| Language | 4 | 2023 | 1471 | 0.310 |
Why?
|
| Prenatal Diagnosis | 3 | 2015 | 1236 | 0.310 |
Why?
|
| Prenatal Care | 6 | 2023 | 1092 | 0.310 |
Why?
|
| Chronic Disease | 9 | 2017 | 9146 | 0.310 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15076 | 0.310 |
Why?
|
| Psychophysiologic Disorders | 1 | 2009 | 228 | 0.300 |
Why?
|
| Severity of Illness Index | 12 | 2021 | 15540 | 0.300 |
Why?
|
| Altruism | 2 | 2021 | 204 | 0.300 |
Why?
|
| Placenta | 6 | 2023 | 1698 | 0.300 |
Why?
|
| Population Dynamics | 3 | 2015 | 302 | 0.300 |
Why?
|
| Learning | 3 | 2014 | 1713 | 0.300 |
Why?
|
| Models, Psychological | 4 | 2019 | 811 | 0.300 |
Why?
|
| Risk-Taking | 2 | 2024 | 986 | 0.300 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2021 | 164 | 0.300 |
Why?
|
| Cause of Death | 4 | 2019 | 3584 | 0.300 |
Why?
|
| Hypercholesterolemia | 2 | 2011 | 1151 | 0.300 |
Why?
|
| Pregnancy Proteins | 4 | 2016 | 229 | 0.290 |
Why?
|
| Organ Size | 9 | 2018 | 2252 | 0.290 |
Why?
|
| Parity | 4 | 2023 | 929 | 0.290 |
Why?
|
| Autoantibodies | 6 | 2019 | 2035 | 0.290 |
Why?
|
| Incidence | 22 | 2018 | 20947 | 0.290 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1526 | 0.290 |
Why?
|
| Irritable Mood | 2 | 2018 | 183 | 0.290 |
Why?
|
| Alcohol Drinking | 9 | 2023 | 3966 | 0.280 |
Why?
|
| Speech | 4 | 2022 | 540 | 0.280 |
Why?
|
| Body Height | 4 | 2015 | 1577 | 0.280 |
Why?
|
| Nervous System | 1 | 2010 | 554 | 0.280 |
Why?
|
| Nitrogen Oxides | 4 | 2020 | 129 | 0.280 |
Why?
|
| Genetic Markers | 2 | 2013 | 2634 | 0.280 |
Why?
|
| Acetaminophen | 2 | 2021 | 545 | 0.280 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 465 | 0.280 |
Why?
|
| Income | 5 | 2022 | 1913 | 0.280 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 676 | 0.270 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2011 | 816 | 0.270 |
Why?
|
| Weight Gain | 2 | 2015 | 2292 | 0.270 |
Why?
|
| Television | 3 | 2014 | 409 | 0.270 |
Why?
|
| Data Collection | 5 | 2022 | 3341 | 0.270 |
Why?
|
| Neural Pathways | 7 | 2018 | 2972 | 0.270 |
Why?
|
| Writing | 1 | 2008 | 206 | 0.270 |
Why?
|
| Genetic Variation | 12 | 2020 | 6544 | 0.270 |
Why?
|
| Fertility | 1 | 2011 | 781 | 0.270 |
Why?
|
| Hypertension | 6 | 2018 | 8480 | 0.260 |
Why?
|
| Smoking Cessation | 5 | 2011 | 2071 | 0.260 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 2015 | 20 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 1364 | 0.260 |
Why?
|
| Deception | 2 | 2017 | 99 | 0.250 |
Why?
|
| Mass Screening | 6 | 2021 | 5255 | 0.250 |
Why?
|
| Cannabis | 4 | 2015 | 439 | 0.250 |
Why?
|
| Infant, Low Birth Weight | 5 | 2021 | 850 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2016 | 552 | 0.250 |
Why?
|
| Hyperkinesis | 2 | 2015 | 89 | 0.250 |
Why?
|
| Reference Values | 11 | 2018 | 4982 | 0.250 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1504 | 0.250 |
Why?
|
| Monitoring, Ambulatory | 1 | 2008 | 355 | 0.250 |
Why?
|
| Milk, Human | 2 | 2022 | 490 | 0.240 |
Why?
|
| Energy Intake | 3 | 2017 | 2148 | 0.240 |
Why?
|
| Cognitive Reserve | 2 | 2015 | 76 | 0.240 |
Why?
|
| Apgar Score | 3 | 2021 | 123 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2019 | 11725 | 0.240 |
Why?
|
| Alleles | 10 | 2019 | 6933 | 0.240 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 522 | 0.240 |
Why?
|
| Chorionic Gonadotropin | 2 | 2017 | 477 | 0.230 |
Why?
|
| Neuropeptides | 1 | 2009 | 942 | 0.230 |
Why?
|
| Personality Development | 2 | 2016 | 245 | 0.230 |
Why?
|
| Abdomen | 1 | 2010 | 1118 | 0.230 |
Why?
|
| Vitamin B 12 | 4 | 2016 | 527 | 0.230 |
Why?
|
| Sexual Partners | 2 | 2018 | 730 | 0.230 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2017 | 337 | 0.230 |
Why?
|
| Hyperthyroidism | 3 | 2014 | 295 | 0.230 |
Why?
|
| Fetal Diseases | 1 | 2009 | 903 | 0.220 |
Why?
|
| Physical Examination | 5 | 2017 | 1237 | 0.220 |
Why?
|
| Benzhydryl Compounds | 4 | 2020 | 845 | 0.220 |
Why?
|
| Anisotropy | 4 | 2020 | 1265 | 0.220 |
Why?
|
| Glucose | 5 | 2023 | 4397 | 0.220 |
Why?
|
| Prediabetic State | 2 | 2021 | 499 | 0.220 |
Why?
|
| Arousal | 1 | 2009 | 1165 | 0.220 |
Why?
|
| Vitamin E Deficiency | 1 | 2002 | 32 | 0.220 |
Why?
|
| Lateral Ventricles | 2 | 2018 | 146 | 0.220 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 11727 | 0.220 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2024 | 128 | 0.220 |
Why?
|
| Genome, Human | 6 | 2020 | 4420 | 0.220 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 3057 | 0.220 |
Why?
|
| Blood Pressure | 11 | 2023 | 8554 | 0.220 |
Why?
|
| Survival Analysis | 5 | 2019 | 10252 | 0.210 |
Why?
|
| Reproducibility of Results | 9 | 2017 | 19905 | 0.210 |
Why?
|
| Violence | 3 | 2023 | 909 | 0.210 |
Why?
|
| Ultrasonography | 5 | 2018 | 5985 | 0.210 |
Why?
|
| Frail Elderly | 3 | 2016 | 693 | 0.210 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 124 | 0.210 |
Why?
|
| Insulin | 4 | 2023 | 6580 | 0.210 |
Why?
|
| Microvessels | 2 | 2017 | 544 | 0.210 |
Why?
|
| Growth Disorders | 3 | 2013 | 645 | 0.210 |
Why?
|
| Pregnant Women | 4 | 2021 | 568 | 0.210 |
Why?
|
| Heterosexuality | 1 | 2024 | 276 | 0.210 |
Why?
|
| Europe | 8 | 2020 | 3339 | 0.200 |
Why?
|
| Inflammation | 3 | 2018 | 10638 | 0.200 |
Why?
|
| Hospitalization | 2 | 2021 | 10262 | 0.200 |
Why?
|
| Pain | 3 | 2017 | 4986 | 0.200 |
Why?
|
| Marijuana Abuse | 3 | 2010 | 403 | 0.200 |
Why?
|
| Age of Onset | 4 | 2019 | 3271 | 0.200 |
Why?
|
| Estrogen Receptor alpha | 1 | 2005 | 577 | 0.200 |
Why?
|
| Haplotypes | 4 | 2019 | 2779 | 0.200 |
Why?
|
| Risk Assessment | 14 | 2021 | 23338 | 0.200 |
Why?
|
| Proteins | 2 | 2015 | 6103 | 0.190 |
Why?
|
| Conduct Disorder | 2 | 2017 | 241 | 0.190 |
Why?
|
| Principal Component Analysis | 4 | 2018 | 940 | 0.190 |
Why?
|
| Housing | 2 | 2018 | 664 | 0.190 |
Why?
|
| Self Concept | 3 | 2021 | 1025 | 0.190 |
Why?
|
| Metabolomics | 2 | 2019 | 1484 | 0.190 |
Why?
|
| Domestic Violence | 2 | 2021 | 176 | 0.190 |
Why?
|
| Thyroiditis, Autoimmune | 2 | 2018 | 101 | 0.190 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2021 | 365 | 0.190 |
Why?
|
| Spouses | 2 | 2015 | 286 | 0.190 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.190 |
Why?
|
| Stuttering | 1 | 2020 | 25 | 0.190 |
Why?
|
| Seizures, Febrile | 2 | 2012 | 111 | 0.180 |
Why?
|
| Prefrontal Cortex | 4 | 2023 | 2147 | 0.180 |
Why?
|
| Synaptic Transmission | 3 | 2016 | 1178 | 0.180 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2019 | 361 | 0.180 |
Why?
|
| Sleep Stages | 2 | 2002 | 686 | 0.180 |
Why?
|
| Somatoform Disorders | 2 | 2016 | 423 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3587 | 0.180 |
Why?
|
| Menopause | 2 | 2022 | 1626 | 0.180 |
Why?
|
| Public Housing | 1 | 2021 | 145 | 0.180 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2266 | 0.170 |
Why?
|
| Docosahexaenoic Acids | 3 | 2019 | 875 | 0.170 |
Why?
|
| Genetics, Behavioral | 2 | 2019 | 53 | 0.170 |
Why?
|
| Students | 2 | 2023 | 1654 | 0.170 |
Why?
|
| Genetics, Population | 4 | 2016 | 934 | 0.170 |
Why?
|
| Body Fluid Compartments | 1 | 2019 | 52 | 0.170 |
Why?
|
| Heart Diseases | 3 | 2019 | 2788 | 0.170 |
Why?
|
| Minority Groups | 4 | 2021 | 1223 | 0.170 |
Why?
|
| Fetal Growth Retardation | 5 | 2021 | 570 | 0.170 |
Why?
|
| Norepinephrine | 1 | 2002 | 909 | 0.170 |
Why?
|
| Ferritins | 1 | 2021 | 590 | 0.170 |
Why?
|
| Septum Pellucidum | 1 | 2019 | 58 | 0.170 |
Why?
|
| Occipital Lobe | 1 | 2021 | 379 | 0.170 |
Why?
|
| Infant Mortality | 2 | 2022 | 754 | 0.170 |
Why?
|
| Public Health | 2 | 2023 | 2603 | 0.170 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2019 | 88 | 0.160 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 102 | 0.160 |
Why?
|
| Fluorocarbons | 1 | 2024 | 452 | 0.160 |
Why?
|
| Apolipoproteins E | 3 | 2014 | 1438 | 0.160 |
Why?
|
| Meta-Analysis as Topic | 4 | 2016 | 1344 | 0.160 |
Why?
|
| Sunlight | 1 | 2020 | 325 | 0.160 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 2018 | 24 | 0.160 |
Why?
|
| Constipation | 2 | 2014 | 546 | 0.160 |
Why?
|
| Bone Density | 4 | 2017 | 3468 | 0.160 |
Why?
|
| Reading | 1 | 2022 | 558 | 0.160 |
Why?
|
| Lipids | 3 | 2019 | 3305 | 0.160 |
Why?
|
| Coffea | 2 | 2015 | 22 | 0.160 |
Why?
|
| Retinal Neurons | 1 | 2018 | 66 | 0.160 |
Why?
|
| Epinephrine | 1 | 2002 | 792 | 0.160 |
Why?
|
| Diet Records | 2 | 2017 | 425 | 0.160 |
Why?
|
| Parietal Lobe | 3 | 2020 | 838 | 0.160 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 188 | 0.160 |
Why?
|
| Orthodontics, Corrective | 1 | 2018 | 75 | 0.160 |
Why?
|
| Arthralgia | 2 | 2015 | 456 | 0.160 |
Why?
|
| Ibuprofen | 1 | 2019 | 236 | 0.160 |
Why?
|
| Impulsive Behavior | 2 | 2022 | 316 | 0.160 |
Why?
|
| Pharmacogenetics | 2 | 2015 | 675 | 0.160 |
Why?
|
| Memory Disorders | 2 | 2015 | 1184 | 0.150 |
Why?
|
| Triglycerides | 4 | 2023 | 2454 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2021 | 673 | 0.150 |
Why?
|
| Health Status Disparities | 3 | 2018 | 1797 | 0.150 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 136 | 0.150 |
Why?
|
| Causality | 4 | 2020 | 1275 | 0.150 |
Why?
|
| Megakaryocytes | 1 | 2021 | 545 | 0.150 |
Why?
|
| Dreams | 1 | 2018 | 147 | 0.150 |
Why?
|
| Malocclusion | 1 | 2018 | 130 | 0.150 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 4258 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 2731 | 0.150 |
Why?
|
| Statistics, Nonparametric | 3 | 2014 | 2886 | 0.150 |
Why?
|
| Environmental Monitoring | 3 | 2014 | 1414 | 0.150 |
Why?
|
| Body Size | 2 | 2017 | 461 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4462 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.150 |
Why?
|
| Minisatellite Repeats | 2 | 2014 | 165 | 0.150 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2017 | 37 | 0.150 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2016 | 19 | 0.150 |
Why?
|
| Vehicle Emissions | 1 | 2022 | 665 | 0.140 |
Why?
|
| Risk Management | 1 | 2020 | 571 | 0.140 |
Why?
|
| Survival Rate | 2 | 2013 | 12788 | 0.140 |
Why?
|
| Mannosidases | 1 | 2016 | 22 | 0.140 |
Why?
|
| Linkage Disequilibrium | 6 | 2019 | 1997 | 0.140 |
Why?
|
| Levonorgestrel | 1 | 2017 | 77 | 0.140 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 479 | 0.140 |
Why?
|
| DNA | 5 | 2021 | 7301 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 817 | 0.140 |
Why?
|
| Research | 1 | 2005 | 1999 | 0.140 |
Why?
|
| Telomere | 1 | 2022 | 910 | 0.140 |
Why?
|
| Observer Variation | 2 | 2013 | 2593 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 292 | 0.140 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2016 | 30 | 0.140 |
Why?
|
| Touch | 1 | 2018 | 306 | 0.140 |
Why?
|
| Lung Diseases | 2 | 2018 | 1886 | 0.140 |
Why?
|
| Denmark | 2 | 2018 | 738 | 0.140 |
Why?
|
| Dental Health Surveys | 1 | 2015 | 43 | 0.140 |
Why?
|
| Metabolism | 1 | 2017 | 196 | 0.130 |
Why?
|
| Electrocardiography | 4 | 2016 | 6442 | 0.130 |
Why?
|
| Trans Fatty Acids | 1 | 2017 | 153 | 0.130 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 711 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.130 |
Why?
|
| Dermatitis, Atopic | 2 | 2013 | 654 | 0.130 |
Why?
|
| Fishes | 2 | 2016 | 569 | 0.130 |
Why?
|
| Meditation | 1 | 2018 | 242 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2016 | 192 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2021 | 8324 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 443 | 0.130 |
Why?
|
| India | 1 | 2022 | 2197 | 0.130 |
Why?
|
| Australia | 4 | 2022 | 1170 | 0.130 |
Why?
|
| Unemployment | 1 | 2017 | 214 | 0.130 |
Why?
|
| Forecasting | 3 | 2023 | 2951 | 0.130 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2017 | 303 | 0.130 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 214 | 0.130 |
Why?
|
| Health Behavior | 3 | 2019 | 2636 | 0.130 |
Why?
|
| Language Tests | 1 | 2015 | 200 | 0.130 |
Why?
|
| Epigenomics | 4 | 2022 | 903 | 0.130 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 1060 | 0.130 |
Why?
|
| Neurosciences | 2 | 2017 | 348 | 0.130 |
Why?
|
| Heart Failure | 3 | 2015 | 10900 | 0.130 |
Why?
|
| Yoga | 1 | 2018 | 253 | 0.130 |
Why?
|
| Time | 1 | 2017 | 542 | 0.130 |
Why?
|
| Gyrus Cinguli | 2 | 2018 | 1091 | 0.130 |
Why?
|
| Health | 2 | 2019 | 394 | 0.130 |
Why?
|
| Prehypertension | 1 | 2015 | 61 | 0.130 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2015 | 55 | 0.130 |
Why?
|
| Epilepsy | 2 | 2010 | 3310 | 0.130 |
Why?
|
| Absorptiometry, Photon | 5 | 2021 | 1725 | 0.130 |
Why?
|
| Receptors, Vasopressin | 1 | 2015 | 112 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2016 | 1157 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 12072 | 0.130 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3200 | 0.130 |
Why?
|
| Orthodontics | 1 | 2015 | 75 | 0.130 |
Why?
|
| Interviews as Topic | 3 | 2017 | 2539 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2019 | 582 | 0.120 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 5751 | 0.120 |
Why?
|
| Fuzzy Logic | 1 | 2014 | 56 | 0.120 |
Why?
|
| Proprotein Convertase 2 | 1 | 2014 | 11 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2012 | 1403 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 462 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 137 | 0.120 |
Why?
|
| Genetic Research | 3 | 2013 | 174 | 0.120 |
Why?
|
| Prognosis | 9 | 2019 | 29063 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1373 | 0.120 |
Why?
|
| Arachidonic Acids | 1 | 2014 | 299 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 780 | 0.120 |
Why?
|
| Social Environment | 3 | 2021 | 1023 | 0.120 |
Why?
|
| Lipase | 1 | 2016 | 314 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2015 | 302 | 0.120 |
Why?
|
| Leukocytes | 1 | 2022 | 2043 | 0.120 |
Why?
|
| Putamen | 1 | 2015 | 291 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2020 | 8949 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 4 | 2016 | 1602 | 0.120 |
Why?
|
| Retrospective Studies | 14 | 2024 | 77449 | 0.120 |
Why?
|
| Ion Transport | 1 | 2015 | 320 | 0.120 |
Why?
|
| Food | 1 | 2019 | 771 | 0.120 |
Why?
|
| Morocco | 1 | 2013 | 28 | 0.120 |
Why?
|
| West Indies | 1 | 2013 | 34 | 0.120 |
Why?
|
| Maternal-Fetal Relations | 2 | 2011 | 25 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2020 | 810 | 0.120 |
Why?
|
| Child Care | 1 | 2015 | 119 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 2 | 2017 | 977 | 0.120 |
Why?
|
| Oral Health | 2 | 2018 | 472 | 0.120 |
Why?
|
| Finland | 3 | 2021 | 602 | 0.120 |
Why?
|
| Placentation | 1 | 2014 | 82 | 0.120 |
Why?
|
| Urban Population | 2 | 2020 | 2021 | 0.120 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1791 | 0.120 |
Why?
|
| Women's Health | 1 | 2023 | 2034 | 0.120 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2015 | 434 | 0.120 |
Why?
|
| Psychotropic Drugs | 2 | 2009 | 894 | 0.120 |
Why?
|
| Language Disorders | 1 | 2014 | 141 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 906 | 0.110 |
Why?
|
| Bone Development | 1 | 2017 | 483 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 1184 | 0.110 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2013 | 134 | 0.110 |
Why?
|
| Eczema | 1 | 2016 | 231 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 514 | 0.110 |
Why?
|
| Genes | 1 | 2017 | 1893 | 0.110 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 231 | 0.110 |
Why?
|
| Birth Order | 1 | 2013 | 95 | 0.110 |
Why?
|
| Arrhythmia, Sinus | 1 | 2012 | 56 | 0.110 |
Why?
|
| Spain | 3 | 2019 | 465 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 651 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2017 | 1563 | 0.110 |
Why?
|
| Turkey | 1 | 2013 | 237 | 0.110 |
Why?
|
| Lung | 2 | 2022 | 9856 | 0.110 |
Why?
|
| Body Weights and Measures | 2 | 2010 | 211 | 0.110 |
Why?
|
| Gait | 2 | 2015 | 793 | 0.110 |
Why?
|
| Bottle Feeding | 1 | 2012 | 66 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2019 | 12208 | 0.110 |
Why?
|
| Forced Expiratory Volume | 4 | 2020 | 1743 | 0.110 |
Why?
|
| Twins, Dizygotic | 1 | 2013 | 236 | 0.110 |
Why?
|
| Body Image | 1 | 2017 | 610 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2017 | 689 | 0.110 |
Why?
|
| Suicide | 1 | 2023 | 1477 | 0.110 |
Why?
|
| Genetic Linkage | 3 | 2017 | 2421 | 0.110 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 500 | 0.110 |
Why?
|
| Pregnancy, High-Risk | 1 | 2012 | 120 | 0.110 |
Why?
|
| Mind-Body Therapies | 1 | 2015 | 247 | 0.110 |
Why?
|
| Employment | 2 | 2009 | 1132 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
| Attitude | 1 | 2017 | 776 | 0.100 |
Why?
|
| Pharmacoepidemiology | 3 | 2013 | 323 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 243 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 418 | 0.100 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 658 | 0.100 |
Why?
|
| Dyslexia | 1 | 2014 | 248 | 0.100 |
Why?
|
| Attitude to Death | 1 | 2015 | 382 | 0.100 |
Why?
|
| Respiratory Sounds | 2 | 2013 | 696 | 0.100 |
Why?
|
| Diabetic Neuropathies | 1 | 2015 | 400 | 0.100 |
Why?
|
| Restless Legs Syndrome | 1 | 2015 | 228 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1184 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2015 | 3047 | 0.100 |
Why?
|
| Waist-Hip Ratio | 3 | 2019 | 517 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 5021 | 0.100 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 91 | 0.100 |
Why?
|
| Vital Capacity | 3 | 2020 | 925 | 0.100 |
Why?
|
| Triiodothyronine | 1 | 2013 | 494 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1401 | 0.100 |
Why?
|
| Twins, Monozygotic | 1 | 2013 | 458 | 0.100 |
Why?
|
| Rural Population | 2 | 2020 | 2210 | 0.100 |
Why?
|
| Phobic Disorders | 1 | 2014 | 439 | 0.100 |
Why?
|
| Vegetables | 1 | 2017 | 1182 | 0.100 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 332 | 0.100 |
Why?
|
| Adaptation, Psychological | 3 | 2018 | 2576 | 0.100 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 1005 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2011 | 41 | 0.100 |
Why?
|
| Computer Simulation | 2 | 2022 | 6196 | 0.100 |
Why?
|
| Placenta Diseases | 1 | 2013 | 199 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 592 | 0.100 |
Why?
|
| Neoplasms | 7 | 2018 | 21683 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 906 | 0.100 |
Why?
|
| Mental Health Services | 1 | 2002 | 1643 | 0.100 |
Why?
|
| Receptors, Nicotinic | 2 | 2014 | 497 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2014 | 237 | 0.100 |
Why?
|
| Carbon | 1 | 2014 | 687 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2016 | 963 | 0.100 |
Why?
|
| Problem Solving | 1 | 2013 | 440 | 0.090 |
Why?
|
| Movement | 2 | 2008 | 1471 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2012 | 286 | 0.090 |
Why?
|
| Psychological Tests | 4 | 2015 | 651 | 0.090 |
Why?
|
| United States | 7 | 2022 | 69872 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1405 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2012 | 311 | 0.090 |
Why?
|
| China | 3 | 2021 | 2248 | 0.090 |
Why?
|
| Anesthetics | 1 | 2016 | 539 | 0.090 |
Why?
|
| Beverages | 1 | 2016 | 820 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2012 | 299 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3508 | 0.090 |
Why?
|
| Consanguinity | 1 | 2012 | 454 | 0.090 |
Why?
|
| Sports | 1 | 2017 | 688 | 0.090 |
Why?
|
| Drinking | 1 | 2011 | 197 | 0.090 |
Why?
|
| Psychology | 1 | 2012 | 356 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 865 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2016 | 2017 | 0.090 |
Why?
|
| Home Childbirth | 1 | 2010 | 51 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.090 |
Why?
|
| Reinforcement, Verbal | 1 | 2009 | 3 | 0.090 |
Why?
|
| Somatosensory Cortex | 1 | 2014 | 528 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 694 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 9648 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 954 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 1613 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3279 | 0.090 |
Why?
|
| Colic | 1 | 2009 | 42 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2012 | 641 | 0.090 |
Why?
|
| Radio Waves | 2 | 2021 | 251 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1813 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1102 | 0.090 |
Why?
|
| Mass Media | 1 | 2012 | 305 | 0.090 |
Why?
|
| Fever | 1 | 2017 | 1616 | 0.090 |
Why?
|
| Blood Circulation | 1 | 2010 | 251 | 0.080 |
Why?
|
| Poverty Areas | 1 | 2011 | 275 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2021 | 6150 | 0.080 |
Why?
|
| Encephalitis | 1 | 2012 | 423 | 0.080 |
Why?
|
| Mental Status Schedule | 3 | 2018 | 321 | 0.080 |
Why?
|
| Thinness | 1 | 2012 | 480 | 0.080 |
Why?
|
| Tacrolimus | 1 | 2012 | 743 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 2647 | 0.080 |
Why?
|
| Artifacts | 1 | 2017 | 1904 | 0.080 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 257 | 0.080 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 489 | 0.080 |
Why?
|
| Dopamine | 1 | 2016 | 1591 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2282 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 855 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2009 | 106 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2002 | 1572 | 0.080 |
Why?
|
| Cerebellar Cortex | 1 | 2009 | 107 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 733 | 0.080 |
Why?
|
| ROC Curve | 2 | 2017 | 3527 | 0.080 |
Why?
|
| Immunoassay | 1 | 2012 | 752 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2017 | 2682 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3520 | 0.080 |
Why?
|
| Femur Neck | 1 | 2010 | 309 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 9959 | 0.080 |
Why?
|
| Biomedical Research | 3 | 2023 | 3309 | 0.080 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 1616 | 0.080 |
Why?
|
| Serotonin | 3 | 2019 | 1017 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2021 | 4740 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 652 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2011 | 291 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 1423 | 0.080 |
Why?
|
| Urban Health | 1 | 2011 | 547 | 0.080 |
Why?
|
| Obstetric Labor, Premature | 1 | 2009 | 279 | 0.080 |
Why?
|
| Substance Abuse Detection | 1 | 2010 | 283 | 0.080 |
Why?
|
| Menarche | 1 | 2011 | 516 | 0.080 |
Why?
|
| Epidemiology | 1 | 2010 | 287 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 822 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12245 | 0.080 |
Why?
|
| Dysthymic Disorder | 1 | 2008 | 74 | 0.080 |
Why?
|
| Growth | 1 | 2010 | 376 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3313 | 0.080 |
Why?
|
| Angiotensinogen | 1 | 2008 | 163 | 0.080 |
Why?
|
| Satiation | 2 | 2019 | 80 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2010 | 6895 | 0.080 |
Why?
|
| Models, Theoretical | 3 | 2019 | 3589 | 0.080 |
Why?
|
| Perception | 1 | 2014 | 1198 | 0.080 |
Why?
|
| Internet | 1 | 2020 | 3064 | 0.080 |
Why?
|
| Analysis of Variance | 5 | 2016 | 6365 | 0.080 |
Why?
|
| Seafood | 1 | 2011 | 384 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2014 | 1183 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.080 |
Why?
|
| Albumins | 1 | 2010 | 569 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2065 | 0.070 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 256 | 0.070 |
Why?
|
| Cholesterol, LDL | 4 | 2023 | 2356 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 3617 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2278 | 0.070 |
Why?
|
| Probability | 2 | 2024 | 2505 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 961 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2212 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1573 | 0.070 |
Why?
|
| Marriage | 1 | 2008 | 339 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1030 | 0.070 |
Why?
|
| Disease Progression | 4 | 2017 | 13284 | 0.070 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
| Diet, Mediterranean | 1 | 2013 | 700 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2013 | 832 | 0.070 |
Why?
|
| Appetite | 2 | 2019 | 243 | 0.070 |
Why?
|
| England | 2 | 2019 | 522 | 0.070 |
Why?
|
| Anger | 2 | 2023 | 402 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2015 | 6256 | 0.070 |
Why?
|
| Social Support | 1 | 2015 | 2118 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2014 | 1422 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3864 | 0.070 |
Why?
|
| Alzheimer Disease | 7 | 2020 | 8037 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2015 | 3420 | 0.070 |
Why?
|
| Pattern Recognition, Visual | 1 | 2011 | 824 | 0.070 |
Why?
|
| Pedigree | 3 | 2018 | 4644 | 0.060 |
Why?
|
| Endocrine System Diseases | 2 | 2009 | 248 | 0.060 |
Why?
|
| Particle Size | 2 | 2019 | 1642 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 1240 | 0.060 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2004 | 36 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1063 | 0.060 |
Why?
|
| Empathy | 1 | 2009 | 474 | 0.060 |
Why?
|
| Pediatrics | 2 | 2017 | 3475 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 365 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1620 | 0.060 |
Why?
|
| Morbidity | 2 | 2021 | 1769 | 0.060 |
Why?
|
| Animals | 9 | 2022 | 168757 | 0.060 |
Why?
|
| DNA Primers | 1 | 2009 | 2892 | 0.060 |
Why?
|
| Mobility Limitation | 1 | 2008 | 409 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 4467 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7880 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 1 | 2004 | 245 | 0.060 |
Why?
|
| Plasticizers | 1 | 2023 | 47 | 0.060 |
Why?
|
| Disabled Persons | 2 | 2009 | 1212 | 0.060 |
Why?
|
| World Health Organization | 1 | 2009 | 1318 | 0.060 |
Why?
|
| Canada | 2 | 2020 | 2065 | 0.060 |
Why?
|
| Terminal Care | 1 | 2015 | 1694 | 0.050 |
Why?
|
| Diet Surveys | 2 | 2017 | 1173 | 0.050 |
Why?
|
| Radiography | 2 | 2013 | 7023 | 0.050 |
Why?
|
| Pre-Eclampsia | 2 | 2011 | 1200 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 647 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 859 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 3079 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5097 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2421 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2006 | 692 | 0.050 |
Why?
|
| Germany | 2 | 2017 | 862 | 0.050 |
Why?
|
| Suicide, Attempted | 2 | 2023 | 1221 | 0.050 |
Why?
|
| Selection Bias | 1 | 2024 | 371 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 403 | 0.050 |
Why?
|
| Cordocentesis | 1 | 2021 | 8 | 0.050 |
Why?
|
| Extremities | 1 | 2007 | 865 | 0.050 |
Why?
|
| Demography | 1 | 2006 | 1656 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 63114 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2012 | 4199 | 0.050 |
Why?
|
| Staff Development | 1 | 2023 | 223 | 0.050 |
Why?
|
| Models, Structural | 1 | 2021 | 361 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2016 | 723 | 0.050 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 1248 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 7279 | 0.050 |
Why?
|
| Paternal Exposure | 2 | 2013 | 89 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 2046 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5319 | 0.050 |
Why?
|
| Recurrence | 2 | 2012 | 8340 | 0.050 |
Why?
|
| Americas | 1 | 2020 | 111 | 0.050 |
Why?
|
| Retirement | 1 | 2022 | 215 | 0.050 |
Why?
|
| Exons | 2 | 2017 | 2437 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2006 | 1609 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2014 | 3265 | 0.050 |
Why?
|
| Palliative Care | 1 | 2015 | 3493 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.050 |
Why?
|
| Developing Countries | 1 | 2013 | 2815 | 0.050 |
Why?
|
| Education | 2 | 2017 | 543 | 0.050 |
Why?
|
| European Union | 1 | 2021 | 158 | 0.050 |
Why?
|
| Echocardiography | 1 | 2013 | 5102 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2023 | 1150 | 0.050 |
Why?
|
| Kidney | 1 | 2015 | 7186 | 0.040 |
Why?
|
| Population Density | 1 | 2020 | 196 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9583 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1726 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 4149 | 0.040 |
Why?
|
| Noise | 1 | 2021 | 279 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 214 | 0.040 |
Why?
|
| Sunburn | 1 | 2020 | 155 | 0.040 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 63 | 0.040 |
Why?
|
| Nucleotides | 1 | 2021 | 464 | 0.040 |
Why?
|
| Health Status Indicators | 2 | 2017 | 969 | 0.040 |
Why?
|
| Heterozygote | 2 | 2016 | 2804 | 0.040 |
Why?
|
| Databases, Factual | 4 | 2017 | 7729 | 0.040 |
Why?
|
| Algorithms | 3 | 2017 | 13881 | 0.040 |
Why?
|
| Fatigue | 2 | 2017 | 1531 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2019 | 144 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2018 | 119 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2018 | 99 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 246 | 0.040 |
Why?
|
| Boredom | 1 | 2017 | 5 | 0.040 |
Why?
|
| Mutation | 4 | 2018 | 29786 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 1401 | 0.040 |
Why?
|
| Urbanization | 1 | 2018 | 104 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 258 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 664 | 0.040 |
Why?
|
| Belgium | 1 | 2017 | 103 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2006 | 2250 | 0.040 |
Why?
|
| Specialization | 1 | 2002 | 777 | 0.040 |
Why?
|
| Base Sequence | 1 | 2009 | 12797 | 0.040 |
Why?
|
| RGS Proteins | 1 | 2017 | 77 | 0.040 |
Why?
|
| Socialization | 1 | 2017 | 87 | 0.040 |
Why?
|
| Poland | 1 | 2017 | 184 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 1011 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 72 | 0.040 |
Why?
|
| Pongo | 1 | 2016 | 4 | 0.040 |
Why?
|
| alpha-Mannosidase | 1 | 2016 | 20 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12026 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 2018 | 118 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2006 | 1916 | 0.040 |
Why?
|
| Weather | 1 | 2018 | 228 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 135 | 0.040 |
Why?
|
| Ethinyl Estradiol | 1 | 2017 | 116 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2016 | 32 | 0.030 |
Why?
|
| Ethanol | 2 | 2015 | 1342 | 0.030 |
Why?
|
| Esthetics, Dental | 1 | 2018 | 250 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1360 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 936 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 62 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 80 | 0.030 |
Why?
|
| Mental Processes | 1 | 2017 | 249 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 244 | 0.030 |
Why?
|
| Dental Care | 1 | 2018 | 262 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2017 | 122 | 0.030 |
Why?
|
| Contraceptive Agents, Female | 1 | 2017 | 135 | 0.030 |
Why?
|
| Italy | 1 | 2017 | 832 | 0.030 |
Why?
|
| Iceland | 1 | 2015 | 183 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2017 | 648 | 0.030 |
Why?
|
| Octamer Transcription Factors | 1 | 2014 | 23 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 373 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2002 | 2453 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2018 | 687 | 0.030 |
Why?
|
| Nonverbal Communication | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2019 | 1472 | 0.030 |
Why?
|
| Delirium | 1 | 2006 | 1609 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2023 | 2488 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 783 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 2014 | 88 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1593 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 434 | 0.030 |
Why?
|
| Health Services Research | 1 | 2002 | 1836 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 365 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2014 | 20 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2018 | 835 | 0.030 |
Why?
|
| Antioxidants | 1 | 2002 | 1663 | 0.030 |
Why?
|
| Kallikreins | 1 | 2016 | 258 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2010 | 587 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 378 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2017 | 563 | 0.030 |
Why?
|
| Ethiopia | 1 | 2016 | 495 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2014 | 136 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2014 | 126 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2016 | 223 | 0.030 |
Why?
|
| Iodides | 1 | 2013 | 41 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2018 | 517 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1583 | 0.030 |
Why?
|
| Medicine | 1 | 2002 | 946 | 0.030 |
Why?
|
| Motion | 1 | 2017 | 798 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2016 | 339 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1381 | 0.030 |
Why?
|
| Personality | 1 | 2017 | 552 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 2013 | 75 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 528 | 0.030 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 265 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 684 | 0.030 |
Why?
|
| Iron | 1 | 2021 | 1774 | 0.030 |
Why?
|
| Nutrition Policy | 1 | 2017 | 488 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 6487 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1169 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2002 | 1643 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2014 | 265 | 0.030 |
Why?
|
| Motivation | 2 | 2017 | 1971 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2018 | 770 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 367 | 0.030 |
Why?
|
| Cohort Effect | 1 | 2012 | 39 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 250 | 0.030 |
Why?
|
| Corticosterone | 1 | 2013 | 310 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 895 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 1463 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 1085 | 0.030 |
Why?
|
| Spirometry | 1 | 2015 | 864 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2013 | 140 | 0.030 |
Why?
|
| Concept Formation | 1 | 2013 | 158 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 3768 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 976 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
| Antigens | 1 | 2018 | 1466 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 328 | 0.030 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2011 | 45 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1855 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1159 | 0.030 |
Why?
|
| Phospholipids | 1 | 2015 | 784 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2018 | 838 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2017 | 1959 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2015 | 584 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2013 | 250 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2002 | 3086 | 0.020 |
Why?
|
| Mice | 4 | 2017 | 81183 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 4266 | 0.020 |
Why?
|
| Hand Strength | 1 | 2014 | 448 | 0.020 |
Why?
|
| Brazil | 1 | 2015 | 1270 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
| Stroop Test | 1 | 2011 | 62 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2017 | 683 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2016 | 478 | 0.020 |
Why?
|
| Maternal-Child Health Centers | 1 | 2010 | 40 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 745 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14722 | 0.020 |
Why?
|
| Melatonin | 1 | 1996 | 721 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 591 | 0.020 |
Why?
|
| Food, Fortified | 1 | 2012 | 191 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 936 | 0.020 |
Why?
|
| Population | 1 | 2011 | 142 | 0.020 |
Why?
|
| Child Health Services | 1 | 2016 | 667 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 604 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1072 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2016 | 560 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2737 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2011 | 105 | 0.020 |
Why?
|
| Micronutrients | 1 | 2013 | 375 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2005 | 14557 | 0.020 |
Why?
|
| Parkinson Disease | 2 | 2016 | 2775 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3920 | 0.020 |
Why?
|
| Genome | 1 | 2018 | 1808 | 0.020 |
Why?
|
| Axons | 1 | 2018 | 1684 | 0.020 |
Why?
|
| Prone Position | 1 | 2011 | 194 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2649 | 0.020 |
Why?
|
| Gene Expression | 2 | 2014 | 7799 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2375 | 0.020 |
Why?
|
| Software | 2 | 2015 | 4443 | 0.020 |
Why?
|
| Lod Score | 1 | 2010 | 614 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9438 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 462 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9386 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1523 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2008 | 5034 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2011 | 339 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Uterus | 1 | 2013 | 711 | 0.020 |
Why?
|
| Child Welfare | 1 | 2013 | 523 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 167 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2018 | 2052 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2013 | 733 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2011 | 475 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 2008 | 31 | 0.020 |
Why?
|
| Medical Audit | 1 | 2010 | 467 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2009 | 232 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3479 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3340 | 0.020 |
Why?
|
| Norway | 1 | 2009 | 448 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9313 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 2309 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2014 | 803 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 279 | 0.020 |
Why?
|
| Nervous System Diseases | 2 | 2009 | 1622 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20129 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1940 | 0.020 |
Why?
|
| Antibodies | 1 | 2015 | 2460 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2934 | 0.020 |
Why?
|
| Diuretics | 1 | 2010 | 592 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 75 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2564 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2006 | 90 | 0.020 |
Why?
|
| Caffeine | 1 | 2011 | 699 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 3251 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 957 | 0.020 |
Why?
|
| Genomics | 2 | 2014 | 5720 | 0.020 |
Why?
|
| Prisoners | 1 | 2009 | 297 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Cities | 1 | 2008 | 513 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 2657 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3674 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 590 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10481 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 707 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2006 | 138 | 0.020 |
Why?
|
| Pancrelipase | 1 | 2004 | 7 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1783 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 7474 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3396 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
| Religion | 1 | 2008 | 356 | 0.020 |
Why?
|
| Parietal Cells, Gastric | 1 | 2004 | 47 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.020 |
Why?
|
| Gastritis, Atrophic | 1 | 2004 | 31 | 0.020 |
Why?
|
| Memory | 1 | 2014 | 2174 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5391 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 688 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3703 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2971 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1303 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3521 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2017 | 3209 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 1988 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2009 | 669 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 573 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2622 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2013 | 2684 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2503 | 0.010 |
Why?
|
| Health Education | 1 | 2008 | 1056 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1660 | 0.010 |
Why?
|
| Alcoholism | 1 | 2011 | 1906 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10180 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3760 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5867 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2006 | 742 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11483 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2009 | 1253 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1736 | 0.010 |
Why?
|
| Cytokines | 1 | 2015 | 7322 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 24260 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 2008 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 854 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9338 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7722 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2715 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15997 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 8863 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13033 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 23403 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13102 | 0.000 |
Why?
|